Cargando…
Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
Refractory acute myeloid leukemia (AML), defined as failure of two cycles of induction therapy at diagnosis or of one cycle at relapse, represents a subgroup with poor outcomes. Haploidentical natural killer cell (NK) therapy is a strategy that is being explored in refractory malignancies. Historica...
Autores principales: | Kulkarni, Uday, Arunachalam, Arun Kumar, Palani, Hamenth Kumar, Nair, Reeshma Radhakrishnan, Balasundaram, Nithya, Venkatraman, Arvind, Korula, Anu, Selvarajan, Sushil, Lionel, Sharon, Balasubramanian, Poonkuzhali, Maddali, Madhavi, Abraham, Aby, George, Biju, Mathews, Vikram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503284/ https://www.ncbi.nlm.nih.gov/pubmed/37706453 http://dx.doi.org/10.1177/09636897231198178 |
Ejemplares similares
-
Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
por: Balasundaram, Nithya, et al.
Publicado: (2022) -
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
por: Kulkarni, Uday, et al.
Publicado: (2020) -
Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
por: Ganesan, Saravanan, et al.
Publicado: (2019) -
Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia
por: Kulkarni, Uday P., et al.
Publicado: (2022) -
Mutation profile in BCR-ABL1-negative myeloproliferative neoplasms: A single-center experience from India
por: Maddali, Madhavi, et al.
Publicado: (2021)